Year in review 2022

Top 10 most read articles of the year 2022

Pan-European disputes once again piqued JUVE Patent readers' interest over 2022, with this year's top ten most-read articles leading with the case between Sandoz, Teva and Novartis over apixaban. Medical devices also came to the fore in the multi-patent action between Dexcom and Abbott, while Munich Regional Court's approach to connected cars and FRAND got the market talking. However, Nokia against Oppo is by the far the most popular case for JUVE Patent's readers over 2022 – not forgetting further changes at the EPO, as well as the market closely following more developments at the UPC.

27 December 2022 by Amy Sandys

Top ten most read, 2022, articles JUVE Patent rounds up its top ten most-read articles of 2022 ©SFIO CRACHO/ADOBE STOCK